Website Header with Language Selector and Dropdowns

N-Nitroso Dexlansoprazole


Catalog Number: CL-DXPZ-NO-01
CAS No.: NA
Mol.F: C16H13F3N4O3S
Mol.W: 398.1
Inv. Status: Justification

Chemical Name: (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1-nitroso-1H-benzo[d]imidazole.

Country of Origin: India

Product Category: Dexlansoprazole Impurities


N-Nitroso Dexlansoprazole is identified by CAS No. NA and is chemically known as (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1-nitroso-1H-benzo[d]imidazole.

N-Nitroso Dexlansoprazole is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Dexlansoprazole.

Page Keywords: Buy N-Nitroso Dexlansoprazole | Purchase N-Nitroso Dexlansoprazole | N-Nitroso Dexlansoprazole suppliers | N-Nitroso Dexlansoprazole manufacturers | N-Nitroso Dexlansoprazole price | N-Nitroso Dexlansoprazole Importer | N-Nitroso Dexlansoprazole Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-DXP-NO-02
CAS No: NA
Mol Wt: 269.2
Mol F: C13H9N4O3+
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-03
CAS No: NA
Mol Wt: 312.3
Mol F: C15H12N4O2S
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-04
CAS No: NA
Mol Wt: 631.6
Mol F: C31H24F3N7O3S
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-05
CAS No: NA
Mol Wt: 350.3
Mol F: C16H13F3N4O2
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-06
CAS No: NA
Mol Wt: 414.4
Mol F: C16H13F3N4O4S
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-07
CAS No: NA
Mol Wt: 345.3
Mol F: C14H11N5O4S
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-08
CAS No: NA
Mol Wt: 428.4
Mol F: C17H15F3N4O4S
Inv. Status: Custom Synthesis
CAT No: CL-DXP-NO-09
CAS No: NA
Mol Wt: 351.3
Mol F: C16H14F3N4O2+
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.